What is compounded semaglutide?

What compounding means

FDA describes compounding as combining, mixing or altering ingredients to create a medication tailored to a patient’s needs. The preparation is made within a compounding setting rather than sold as the approved manufacturer’s finished drug. The term names a production category; it does not by itself establish why a particular patient needs the preparation, who made it or whether all conditions for the applicable legal pathway have been met. [1]

A telehealth company can advertise and coordinate access to a compounded program while a different organization prescribes and another pharmacy prepares the medicine. The storefront is therefore not necessarily the compounder. Identify the actual clinical organization and pharmacy when discussing the product. Our provider profiles preserve the primary-source information available about those relationships and flag details that the records do not establish. [1][3]

Semaglutide names an ingredient, not the complete product

The semaglutide heading alone does not tell you the formulation, package, concentration or whether another ingredient is included. FDA’s semaglutide product notice describes differences among compounded preparations, including packaging and added ingredients. A label such as semaglutide plus B12 identifies a combination, while an injection and sublingual drops describe different routes. Keep the full product description when comparing a service’s advertised offer. [4][5]

Do not use this general definition to authenticate what is in an individual package. FDA reports fraudulent compounded GLP-1 labels that name nonexistent pharmacies or pharmacies that did not prepare the product. The prescribing team and actual dispensing pharmacy are the relevant contacts for resolving a product-identity question. A familiar ingredient name on an advertisement is not evidence about the contents of a specific vial. [2]

How it differs from an FDA-approved brand

Wegovy and Ozempic are brand names associated with approved finished products. Their approvals do not extend to every preparation described with the semaglutide ingredient name. FDA’s drug-approval process reviews evidence and labeling for a particular finished product and intended use. A compounder does not inherit that approval merely by referring to the brand’s ingredient or presenting a similar price-comparison label. [6][1]

The branded product, a compounded preparation and an approved generic are separate regulatory categories. FDA says an approved generic must meet its approval requirements, including the relevant formulation and bioequivalence requirements. A compounded prescription is not the same route to market. Describing an offer as generic semaglutide can therefore obscure the category readers need to understand. Our approval guide explains these terms without predicting when a future generic may become available. [7][1]

Base and salt forms need accurate identification

FDA identifies semaglutide sodium and semaglutide acetate as different active ingredients from those used in approved drugs. The agency says it does not have information establishing the same chemical and pharmacologic properties and is not aware of a lawful basis for their use in compounding. A reader should not collapse those names into a single verified product identity because a seller uses the broad semaglutide heading. [2]

Ask the pharmacist for the exact ingredient description if the label or provider explanation is unclear. This is an identification question, not a reason to translate concentrations or modify instructions yourself. The directory’s formulation labels reflect recorded advertisements; they cannot determine chemical identity through marketing text alone. The pharmacy must explain the preparation it proposes to dispense. [3][4]

The current regulatory context is post-shortage

FDA’s April 2026 reminder states that semaglutide is not on the drug shortage list or the 503B bulks list. It describes conditions for patient-specific 503A compounding and separate restrictions for 503B facilities. The meaning of compounded semaglutide has not changed into approved generic semaglutide because a service continues advertising it. The current conditions need to be considered for the actual prescription and compounder. [8][9]

Older shortage-era explanations can be useful history, but they do not supply a continuing blanket permission to sell routine copies. Our legal-framework and shortage-status guides keep those dates and pathways separate. The definition on this page does not adjudicate a pharmacy’s compliance or determine that a patient qualifies for a particular compounded preparation. Those product-specific questions require the responsible clinical and dispensing organizations. [8]

How the directory uses the term

We use the compounded-semaglutide section for services whose primary sources advertise that product category. Recorded formulation labels and original source dates remain visible. The provider-access guide shows the roster and the price guide separates supported recurring injection examples from other formulations and commitments. Inclusion is not an approval claim, a pharmacy-inventory report or a clinical ranking. [5][10][11]

Before comparing a quote, identify the full preparation, the prescribing process and the payment term. A semaglutide label does not settle whether care is bundled, whether a plan is prepaid or whether every fee is known. Those financial facts remain distinct from FDA approval and compounding conditions. This lets the directory explain a service’s advertised offer without implying that a lower price establishes an interchangeable product. [12][1]

A formulation label is more than an ingredient heading

Gentle Health provides a concrete example of why the full label matters: its site advertises semaglutide injections and sublingual drops as different options. A reader searching only the ingredient can therefore encounter two differently described preparations at the same organization. The difference should remain visible in an access or price comparison. The definition compounded semaglutide does not resolve which one was prescribed or establish that one formulation can replace the other. Ask the care team to identify the actual preparation before applying a quote or comparing it with another provider’s offer. [5][1]